AARD News

Class Action Lawsuit Filed Against Aardvark Therapeutics, Inc. (AARD) - Recover Losses - Contact Levi & Korsinsky Before October 13, 2026

Pomerantz LLP Announces Commencement of Class Action Lawsuit Against Aardvark Therapeutics, Inc. – AARD

AARD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Pomerantz LLP Brings Class Action Lawsuit Against Aardvark Therapeutics, Inc. – AARD

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AARD

Investors in Aardvark Therapeutics, Inc. (AARD): Protect Your Rights – Contact Levi & Korsinsky Before October 13, 2026

Investors Urged to Contact Levi & Korsinsky for Information Before October 13, 2026 – Aardvark Therapeutics, Inc. (AARD)

Securities Fraud Class Action Filed Against Aardvark Therapeutics, Inc. (AARD) – Levi & Korsinsky Reminds Investors of October 13, 2026

October 13, 2026 Deadline: Join Class Action Lawsuit Against Aardvark Therapeutics, Inc. (AARD) – Contact Levi & Korsinsky

AARD INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026 Ready to Announce with Confidence?